The PT/INR test assesses the prothrombin time (PT) of blood to undergo coagulation, and the test is used to ensure the therapeutic range of anticoagulant therapy to prevent blood clots or excessive bleeding. The results obtained are standardised by the International Normalized Ratio (INR) across different labs and reagents.